Lanzamiento Enero 2027

Ensayo controlado aleatorizado2017Acceso abierto

Randomized Controlled Trial of High-Volume Energy Drink Versus Caffeine Consumption on ECG and Hemodynamic Parameters

Fletcher EA, Lacey CS, Aaron M, Kolasa M, Occiano A, Shah SA

Journal of the American Heart Association · 53 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Gobierno
U.S. Department of Defense

Según 1 financiador declarado y la declaración de financiación del texto completo.

Publicación

Publicado
2017-04-26 · J Am Heart Assoc · vol. 6 · número 5
Editorial
Wiley
Citado
97 citas · más que el 97% de estudios similares · 6.0× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
42 trabajos
Acceso
Acceso abierto (revista) · CC-BY-NC
Áreas de investigación
Coffee research and impacts · Cannabis and Cannabinoid Research · Pharmacology and Obesity Treatment
Palabras clave
Medicine, Caffeine, Blood pressure, Crossover study, Heart rate, Diastole, Cardiology, QT interval, Anesthesia, Hemodynamics, Internal medicine, Placebo
MeSH
heart conduction system, humans, caffeine, central nervous system stimulants, electrocardiography, risk assessment, cross-over studies, double-blind method, predictive value of tests, blood pressure, heart rate, time factors, adolescent, adult, female, male, arrhythmias, cardiac, hemodynamics, young adult, energy drinks

6 autores

  • Emily A. Fletcher🇺🇸Grant Medical Center
  • Carolyn S. Lacey🇺🇸Grant Medical Center
  • Melenie Aaron🇺🇸Grant Medical Center
  • Mark W. Kolasa🇺🇸Grant Medical Center
  • Andrew Occiano🇺🇸University of the Pacific
  • Sachin A. Shah🇺🇸University of the Pacific; Grant Medical Center

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Caffeine in doses <400 mg is typically not considered arrhythmogenic, but little is known about the additional ingredients in energy drinks. We evaluated the ECG and blood pressure (BP) effects of high-volume energy drink consumption compared with caffeine alone.

Methods and results

This was a randomized, double-blind, controlled, crossover study in 18 young, healthy volunteers. Participants consumed either 946 mL (32 ounces) of energy drink or caffeinated control drink, both of which contained 320 mg of caffeine, separated by a 6-day washout period. ECG, peripheral BP, and central BP measurements were obtained at baseline and 1, 2, 4, 6, and 24 hours post study drink consumption. The time-matched, baseline-adjusted changes were compared. The change in corrected QT interval from baseline in the energy drink arm was significantly higher than the caffeine arm at 2 hours (0.44±18.4 ms versus -10.4±14.8 ms, respectively; P=0.02). The QTc changes were not different at other time points. While both the energy drink and caffeine arms raised systolic BP in a similar fashion initially, the systolic BP was significantly higher at 6 hours when compared with the caffeine arm (4.72±4.67 mm Hg versus 0.83±6.09 mm Hg, respectively; P=0.01). Heart rate, diastolic BP, central systolic BP, and central diastolic BP showed no evidence of a difference between groups at any time point. Post energy drink, augmentation index was lower at 6 hours.

Conclusions

The corrected QT interval and systolic BP were significantly higher post high-volume energy drink consumption when compared with caffeine alone. Larger clinical trials validating these findings and evaluation of noncaffeine ingredients within energy drinks are warranted.

Clinical trial registration

URL: http://www.clinicaltrials.gov. Unique identifier: NCT02023723.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY-NC).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.